The Regulatory Authority of Germany (Regierung von Oberbayern) has concluded the follow-on audit of Dr. Reddy’s Laboratories’ Formulations manufacturing facility in Duvvada, Vishakapatnam, on November 09, 2018. The…
Dr. Reddy’s Laboratories has launched Atomoxetine Capsules, USP, a therapeutic equivalent generic version of Strattera (atomoxetine) Capsules in the United States market…
Dr. Reddy’s Laboratories has reported results for second quarter ended September 30, 2018. The company has reported over 3 fold jump in…
Dr. Reddy’s Laboratories has received an approval for Aspirin and Extended-Release Dipyridamole Capsules, a therapeutic equivalent generic version of Aggrenox (aspirin and…
Dr. Reddy’s Laboratories has entered into a definitive agreement for the sale of its API manufacturing business unit located in Jeedimetla in…
Dr. Reddy’s Laboratories has launched Colesevelam HCI Tablets, USP, a therapeutic equivalent generic version of WELCHOL (colesevelam HCI) Tablets in the United…
Men’s doubles match witnessed a brilliant comeback from Manu and Sumeeth against compatriots Arjun MR and Ramchandran Shlok in the 51-minute quarter-final. …